Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00691639 · ClinicalTrials.gov registry record

Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)

A clinical trial, sponsored by Alcon Research.

Completed
Registry status
1,000
Enrollment target

NCT00691639: Completed study, sponsored by Alcon Research.

NCT00691639 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00691639 has completed, sponsored by Alcon Research.

COMPLETED
Registry status
1,000 participants
Enrollment target

Study Summary

The objective of this study is to obtain blood samples from patients who are or were participants in any Alcon AL-3789 clinical trial. Association will be conducted to search for genetic markers in patients with glaucoma or ocular hypertension.

Interventions

  • OTHER Blood Collection Only

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2008-03
Alcon Research

275 total trials

What the finished NCT00691639 record still lists

NCT00691639 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Blood Collection Only is the first listed.

NCT00691639 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00691639 about?

NCT00691639 is a clinical study titled "Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)". The objective of this study is to obtain blood samples from patients who are or were participants in any Alcon AL-3789 clinical trial. Association will be conducted to search for genetic markers in patients with glaucoma or ocular hypertension.

What is the current status of trial NCT00691639?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2008-03.

What interventions are being tested in trial NCT00691639?

The interventions under investigation include: Blood Collection Only (OTHER).

Who is sponsoring clinical trial NCT00691639?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00691639, the US trial registry maintained by the National Library of Medicine. NCT00691639 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.